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) is the second most abundant transition metal in 
biological systems and is an essential component of many 




 is tightly 
held in these proteins,
2,3
 labile zinc pools (weakly bound or free) 
also exist over various concentrations ranging from nanomolar to 







 Changes in such Zn
2+
 
concentrations may affect a fundamental function of cells; 
therefore, these Zn
2+
 pools are homeostatically regulated in 
response to the cellular Zn
2+
 status. 
To understand the biological roles of the labile Zn
2+
 in cells 
and tissues, numerous Zn
2+
-selective fluorescent sensors have 
been developed.
7
 Although, small molecules and protein-based 
fluorescent sensors
8
 have afforded many important insights into 




 most of these sensors 
require multi-step synthesis (usually exceeding five steps), 
including complicated synthetic reactions or labor-intensive 
purification procedures. Therefore, in these cases, essential 
redesigning of the molecules is needed to alter the chemical 
properties of these sensors such as binding affinity, metal ion 
selectivity, and water solubility. Regarding these points, a metal 
ion sensor based on a peptide scaffold offers several advantages. 
For example, structural optimization of peptides with appropriate 
binding affinity for Zn
2+
 can be achieved by alterations of amino 
acid sequences. Unnatural amino acids or synthetic organic 
molecules can also be easily introduced into the terminal 
sequences and/or the amino acid side chains, which is hard to 
achieve with proteins, by using standard solid-phase synthetic 
techniques. Although a few peptide-based fluorescent sensors for 
Zn
2+
 have been reported,
10
 these sensors have some limitations 
for optical imaging applications. Particularly, they require 
ultraviolet excitation that can damage biological samples and 
induce auto-fluorescence from endogenous cellular molecules 
such as the reduced forms of nicotinamide adenine dinucleotide 
(NADH) and flavin adenine dinucleotide (FAD).
11 





 complexes), which exhibit sensitized-lanthanide emission 
upon Zn
2+
 binding, are capable of overcoming such the 
limitations observed in UV-excitable fluorescent sensors. 
Because of long luminescence excited-state lifetimes of sub-
milliseconds of these metals, auto-fluorescence and scattered 
light decay can be effectively eliminated by taking a delay time 
in the emission collection.
12
 Furthermore, a shorter exposure time 
of UV irradiation in pulsed excitation can reduce photodamage 
by the excitation light during live-cell imaging. However, few 





 Herein, we present the design and photophysical 
properties of a short peptide sensor consisting of less than 10 
amino acids (TbOTZ, Scheme 1) for detecting Zn
2+
 using a time-
resolved luminescence (TRL) spectroscopy. Furthermore, we 






A synthetic peptide bearing a lanthanide complex, TbOTZ exhibits a decrease of chromophore 





binding. Thus, TbOTZ can be a valuable tool for ratiometric sensing of Zn
2+
 as well as for time-
resolved fluorescence detection with a single molecule. 
2009 Elsevier Ltd. All rights reserved. 
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The present sensor, TbOTZ, where the sequence is 
DOTA(Tb)-HHHPGHHH-D(cs124)G, essentially consists of 
three domains: carbostyril 124 (cs124) at the C-terminus as the 
energy donor to the Tb
3+
 core, two histidine trimers linking with 
the -turn sequence of proline-glycine (PG), which pre-organizes 
the metal-binding cavity, and a Tb
3+
 complex supported by a 
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate (DOTA) 
ligand at the N-terminus. In general, lanthanides are sensitized 
via energy transfer from an appropriate excited chromophore 
(antenna effect) rather than by direct excitation of spin-forbidden 
f-f transitions.
12
 The efficiency of energy transfer from the 
chromophore to the metal ion strongly depends on the distance 
separating the two components. When the metal-binding motif 
recognizes Zn
2+
 and forms the complex, the cs124 chromophore 
becomes spatially close to the Tb
3+
 core, resulting in the increase 
in sensitized emission intensity. 
We first synthesized a Fmoc-protected amino acid with cs124, 
Fmoc-Asp(cs124)-OH, according to a reported procedure.
14
 Prior 
to starting the synthesis of the designed peptide by Fmoc solid-
phase peptide synthesis, the resins were pre-treated with Fmoc-
glycine in order to mount Fmoc-Asp(cs124)-OH on the resin 
efficiently. At the end of the solid-phase synthesis, the N-
terminus of the peptide on the resin was modified with tris(tert-
butyl)ester of DOTA ligand having a free carboxyl group. After 
cleavage from the resin, the pure peptide of apo form was 
obtained by HPLC equipped with an ODS column (XBridge, 
Waters). Chelation of the peptide with Tb
3+
 followed by 
purification with gel permeation chromatography with Sephadex 
G10 gel (GE-Healthcare) gave the pure sensor peptide, TbOTZ, 
which was confirmed by ESI-TOF mass spectroscopy (Fig. S1 
and S2). 
As TbOTZ is highly water soluble, we measured the 
photophysical properties of the sensor peptide under 
physiological conditions (50 mM HEPES, pH 7.4, 0.1 M KNO3) 
without any co-solvent. TbOTZ exhibited a strong emission band 
at 365 nm corresponding to cs124 fluorescence upon excitation at 
330 nm, which is the absorption maximum of TbOTZ (Fig. S3). 
Addition of Zn
2+
 triggers the gradual decrease of the intensity at 
365 nm and concomitant increase of the intense peaks at 490, 545, 
and 583 nm, those are attributed to the Tb
3+




FJ (J = 6, 5, and 4, respectively), with a distinct isoemissive 
point at 392 nm (Fig. 1). The quantum yields of cs124 
fluorescence and Tb
3+
 luminescence were decreased and 
increased, respectively, upon binding with Zn
2+
 (Table 1). These 
spectral features of TbOTZ indicate that this peptide sensor 
makes ratiometric detection of Zn
2+
 possible, which, in principle, 
offers the accurate determination of [Zn
2+
] by monitoring the 
emission intensities of cs124 and Tb
3+
. The formation of the 
peptide-Zn
2+
 complex with a 1:1 stoichiometry was confirmed by 
the Hill plot, where a Hill coefficient is calculated to be one by 
the slope of the line (Fig. S4). The plots of fluorescence 
intensities at 365 and 545 nm as a function of [Zn
2+
] can be well 
fitted by a pseudo-first-order equation (inset in Fig. 1), from 
which the apparent dissociation constant was calculated to be Kd 
= 160 ± 10 M, indicating that TbOTZ is suitable for detecting 
Zn
2+
 concentrations ranging from 50 to 750 M. The lower 
affinity sensors with Kd values in the mid- to high-micromolar 
range has been required to understand the roles played by zinc in 
the physiological and pathological functioning of the brain, 
where near-millimolar concentrations of Zn
2+
 are presumed to 
exist in synaptic clefts.
4
 The peptide sensor TbOTZ would have a 
















We next performed TRL measurements with TbOTZ for 
detecting Zn
2+
. When taking a delay time of 0.05 ms, a 15-fold 
enhancement of Tb
3+
 luminescence was observed upon addition 
of Zn
2+
 ions, whereas the fluorescence from cs124 as well as 
scattering light from pulses of the excitation lamp was 
completely eliminated (Fig. 2). This result allowed the detection 
of Zn
2+














Scheme 1. (a) Structure of the peptidic Zn2+ sensor TbOTZ. (b) Schematic 
representation of energy transfer induced by Zn2+ binding. 
Figure 1. Emission spectral change (excitation at 330 nm) of TbOTZ (10 
M) upon addition of various concentrations of Zn2+ (0–1.2 mM). These 
spectra were acquired in 50 mM HEPES buffer (pH 7.4, 0.1 M KNO3). 
Inset: plots of fluorescence intensities at 365 nm (circle) and 545 nm 
(triangle) with best-fit curves for the Kd of 160 M. 
Figure 2. Time-resolved emission spectra (excitation at 330 nm) of 
TbOTZ (10 M) upon addition of Zn2+ (0–1.0 mM, 0.1 mM each). These 
spectra were measured in 50 mM HEPES buffer (pH 7.4, 0.1 M KNO3) 
using a delay time of 0.05 ms and a gate time of 1.00 ms.  
our knowledge, TbOTZ is the first example that can monitor the 
changes of [Zn
2+
] not only by ratiometric analysis of emission 
peaks but also by TRL spectroscopy. 
 
Table 1. Luminescence and Chemical Properties of TbOTZ 
a Quantum yields were calculated using quinine ( = 0.53 in 0.1 N H2SO4) 
for cs124 fluorophore and [Ru(bipy)3]Cl2 ( = 0.028 in water) for Tb
3+ 
complex as standards, respectively. 
b In 50 mM HEPES buffer solutions at pH 7.4 and pD 7.4. 
cq values were estimated using the equation qTb = 5(H2O
–1 – D2O
–1 – 0.06). 
The selectivity profiles of TbOTZ were examined by titrations 
with various biologically important metal ions (Fig. 3). High 
concentrations (10 mM) of alkali and alkali earth metal ions, 
which are highly abundant species in living cells, induced little 
emission spectral change of TbOTZ. More importantly, this 
exerted a negligible effect on the fluorescence response for Zn
2+
, 
indicating the potential use of this peptide sensor for biological 











 induced fluorescence quenching and 
interfere with Zn
2+
 binding (Fig S5), these free cations would 
have little influence in biological samples, because these 





 It should be noted that the fluorescence of 
TbOTZ was not affected by Cd
2+
 (Fig S5), which often exhibits 
the same or similar fluorescence responses to Zn
2+




















competitive inhibition of the response because of their chemical 
similarities. This may suggest the metal-binding site consisting of 
six histidines in TbOTZ creates a highly restricted binding pocket 
for first-row transition metals rather than for Cd
2+
 with large 
ionic radius. 
In order to confirm whether the Zn
2+
-induced luminescence 
enhancement occurred with conformational change of the peptide 
platform, lifetimes of Tb
3+
 luminescence () were measured in 
the absence and presence of Zn
2+
 (Table 1 and Fig. S6). Both 
before and after the Zn
2+
 binding, the numbers of coordinated 
water molecules (q values) on the Tb
3+
 center were unchanged to 
be ~1. Because the emission intensity of lanthanide ions is 
directly dependent on the q value, some lanthanide-based 
luminescent sensors have utilized the displacement of metal-
bound water by an analyte-binding as a luminescent switch of the 
sensor.
16
 In case of TbOTZ, however, the luminescence OFF-ON 
mechanism involving water displacement can be excluded. We 
then compared the phosphorescence spectra of TbOTZ before 
and after binding with Zn
2+
. In the absence of Zn
2+
, the 
phosphorescence emission (22,500 cm
–1
) from the triplet state of 
the cs124 chromophore
17
 and intense sharp peaks of Tb
3+
 were 
observed in MeOH/EtOH (4/1, v/v) glasses at 77 K (Fig. S7). On 
the other hand, the triplet state completely disappeared upon the 
addition of Zn
2+
. These indicate that Zn
2+
 binding triggers 
enhancement of the energy transfer rate from the triplet excited-
state of chromophore to Tb
3+
, which strongly support the 
conclusion that the terminals of TbOTZ become spatially close as 
illustrated in Scheme 1. 
Finally, we tested the application of TbOTZ to TRL detection 
of Zn
2+
 in a biological buffer containing 10% fetal bovine serum 
(FBS). TRL measurement provided distinct turn-on response to 
Zn
2+
 without being affected by biological contaminants in the 
serum (Fig. S8).  
In conclusion, we have successfully developed a new peptidic 
dual functional sensor TbOTZ, which enables both the 
ratiometric and TRL measurements for the detection of Zn
2+
 with 
a single molecule. Furthermore, TbOTz is able to correctly detect 
Zn
2+
 in the presence of FBS by TRL measurement. The main 
advantage of peptidic sensors is the high versatility of the sensor 
design. For instance, the binding affinity for Zn
2+
 would be 
increased by tuning the -turn sequence of the peptide in a way 
that enables peptide to adopt a more stable -hairpin 
conformation.
10d
 Moreover, the metal-binding sequence in 
TbOTZ can be altered with other chelatable amino acids such as 
methionine and aspartic acid in order to change the metal ion 
selectivity. Such the peptide-based fluorescence probes would be 
useful chemical sensors for monitoring extracellular and 
environmental metal ion concentrations. 
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Figure 3. Metal ion selectivity profiles of TbOTZ (10 M) in 50 mM 
HEPES (pH 7.4, 0.1 M KNO3). Bars represent (a) emission intensity ratio 
(F545/F365) and (b) luminescence intensity at 545 nm to various metal 
cations (10 mM for Na+, K+, Ca2+, and Mg2+, 500 M for all other metals); 
1: no metal; 2: Mn2+; 3: Fe2+; 4: Co2+; 5: Ni2+; 6: Cu2+; 7: Zn2+; 8: Cd2+; 9: 
Na+; 10: K+; 11: Mg2+; 12: Ca2+; 13: Na++Zn2+; 14: K++Zn2+; 15: 
Mg2++Zn2+; 16: Ca2++Zn2+. 
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